What is Deferiprone?
Deferiprone (tradenames include Ferriprox) is a drug that chelates iron and is used to treat thalassaemia major. On October 14, 2011, it was approved for use in the US under the FDA’s accelerated approval program.
Deferiprone was at the center of a protracted struggle between Nancy Olivieri, a Canadian haematologist and researcher, and the Hospital for Sick Children and pharmaceutical giant Apotex, that started in 1996 and delayed approval of the drug in North America. Dr. Olivieri's data suggested deferiprone leads to progressive hepatic fibrosis.